1. Home
  2. NXST vs IMVT Comparison

NXST vs IMVT Comparison

Compare NXST & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexstar Media Group Inc.

NXST

Nexstar Media Group Inc.

HOLD

Current Price

$187.57

Market Cap

6.2B

Sector

Industrials

ML Signal

HOLD

Logo Immunovant Inc.

IMVT

Immunovant Inc.

HOLD

Current Price

$33.73

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXST
IMVT
Founded
1996
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
5.8B
IPO Year
2002
2019

Fundamental Metrics

Financial Performance
Metric
NXST
IMVT
Price
$187.57
$33.73
Analyst Decision
Strong Buy
Buy
Analyst Count
8
8
Target Price
$263.75
$33.00
AVG Volume (30 Days)
278.7K
2.3M
Earning Date
05-07-2026
05-28-2026
Dividend Yield
3.67%
N/A
EPS Growth
N/A
N/A
EPS
5.09
N/A
Revenue
$4,949,000,000.00
N/A
Revenue This Year
$11.38
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$37.19
N/A
Revenue Growth
N/A
N/A
52 Week Low
$164.00
$13.79
52 Week High
$254.30
$36.29

Technical Indicators

Market Signals
Indicator
NXST
IMVT
Relative Strength Index (RSI) 37.28 64.98
Support Level $182.45 $22.84
Resistance Level $210.51 N/A
Average True Range (ATR) 8.22 1.92
MACD -0.80 0.61
Stochastic Oscillator 13.44 76.17

Price Performance

Historical Comparison
NXST
IMVT

About NXST Nexstar Media Group Inc.

Nexstar is the largest television station owner-operator in the United States with over 200 stations in 116 markets, reaching 220 million people. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. Pending approval, Nexstar's merger with Tegna would bring Nexstar's station total to 259 in 133 markets, reaching 80% of the US population. Nexstar also owns NewsNation (formerly WGN), a cable news network, 75% of the fifth national broadcaster, the CW, and a 31% stake in Food Network and Cooking Channel.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

Share on Social Networks: